Citation Impact
Citing Papers
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY
1971 StandoutNobel
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
1974
Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation**
2021 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
A view on drug resistance in cancer
2019 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
1991
Induction of angiogenesis during the transition from hyperplasia to neoplasia
1989 StandoutNature
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Drug Delivery to the Central Nervous System: General Principles and Relevance to Therapy for Infections of the Central Nervous System
1989
Molecular Analysis of Yeast and Human Type II Topoisomerases
1999 Nobel
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation
1989
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Proposed mechanisms of action in thalidomide embryopathy
1988
Angiogenesis as a therapeutic target
2005 StandoutNature
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Prostaglandin Production by Experimental Tumours and Effects of Anti-inflammatory Compounds
1972
On the Physiologic Significance of Monoamine Oxidase in Brain
1957 Science
The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine and serotonin
1957
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds
1964 StandoutNatureNobel
Colony Inhibition of Fibroblasts from Chimeric Dogs Mediated by the Dogs' Own Lymphocytes and Specifically Abrogated by Their Serum
1970 StandoutNobel
O-methylation, the Principal Route of Metabolism of Epinephrine in Man
1958 StandoutScienceNobel
The significance of the circulating cancer cell
1975
Purification and Properties of Hydroxyindole-O-methyl Transferase
1961 StandoutNobel
Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein.
1975 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Anti-Angiogenesis
1972
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Adjuvant chemotherapy in head and neck cancer
1992
Enzymatic O-Methylation of Epinephrine and Other Catechols
1958 StandoutNobel
Tumor Angiogenesis: Therapeutic Implications
1971 Standout
Molecular probes for the development and plasticity of neural crest derivatives
1985 StandoutNobel
Lymphocytes and Transplantation Immunity
1967
Rodent eccrine sweat glands: A case of multiple efferent innervation
1984
Thalidomide is an inhibitor of angiogenesis.
1994 Standout
Tumour angiogenesis factor (TAF) in human and animal tumours
1976
Angiogenic Factors
1987 StandoutScience
The pathogenesis of cancer metastasis
1980 StandoutNature
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
Natural Products as Sources of New Drugs over the Last 25 Years
2007 Standout
Functional requirement of aquaporin-5 in plasma membranes of sweat glands
2002 StandoutNobel
Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts
1981 StandoutNobel
Suppression of the Daily Rhythm in Tyrosine Transaminase Activity by Acute Elevation of Norepinephrine
1968 StandoutNatureNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Two-Photon Absorbing Nanocrystal Sensors for Ratiometric Detection of Oxygen
2009 StandoutNobel
Lysosomotropic agents
1974 StandoutNobel
The Biology of Cancer Invasion and Metastasis
1978
Adjuvant Chemotherapy in Head and Neck Cancer.
1992
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
Evidence for neurotransmitter plasticity in vivo: Developmental changes in properties of cholinergic sympathetic neurons
1983
Some Serum Protein Nitrogen Mustard Complexes with High Chemotherapeutic Selectivity
1967 Nature
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)
1972 StandoutNatureNobel
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Geometric Control of Cell Life and Death
1997 StandoutScience
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
O-Methylation of Epinephrine and Other Catechols in vitro and in vivo
1957 StandoutScienceNobel
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Observations on the fate of indolalkylamines in the organism
1955
Works of K. Hellmann being referenced
Prolongation of Skin Homograft Survival by Thalidomide
1965
Antilymphocytic serum and tumour dissemination.
1968
Metastases and the Normalization of Tumour Blood Vessels by ICRF 159: A New Type of Drug Action
1972
Dynamics of tumour angiogenesis: Effect of razoxane-induced growth rate slowdown
2003
Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic
1970
Vascular changes in tumours after treatment with ICRF 159.
1971
Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer
1978
Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines
1998
Biological Properties of ICRF-159 and Related Bis(dioxopiperazine) Compounds
1982
Chemotherapy of Cancer
1968 Nature
Drug-induced inhibition of tumour cell dissemination.
1970
Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.
1974
Cholinesterase and amine oxidase in the skin: a histochemical investigation
1955
The antitumour activity of a series of benzothiophenes
1967
Effect of Thalidomide on the Graft versus Host Reaction
1966 Nature
Metastasis and Triton WR 1339
1973
Pigment formation from tryptamine and 5‐hydroxytryptamine in tissues: a contribution to the histochemistry of amine oxidase
1953
Control of Malignant Metastases by ICRF 159
1969 Nature
Enhanced cerebrovascular permeability by Metrazol: significance for brain metastases
1983
IMMUNOSUPPRESSION BY THALIDOMIDE: IMPLICATIONS FOR TERATOLOGY
1966